Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Otte, C. Articles by Whooley, M. A. Search for Related Content PubMed Citation Articles by Otte, C. Articles by Whooley, M. A. Neuroendocrinology Depression Symptoms/Dimensions

Depressive Symptoms and 24-Hour Urinary Norepinephrine Excretion Levels in Patients With Coronary Disease: Findings From the Heart and Soul Study

OBJECTIVE: Depressive symptoms are associated with an increased risk of cardiac events in patients with heart disease. Elevated catecholamine levels may contribute to this association, but whether depressive symptoms are associated with catecholamine levels in patients with heart disease is unknown. METHOD: The authors examined the association between depressive symptoms (defined by a Patient Health Questionnaire score 10) and 24-hour urinary norepinephrine, epinephrine, and dopamine excretion levels in 598 subjects with coronary disease. RESULTS: A total of 106 participants (18%) had depressive symptoms. Participants with depressive symptoms had greater mean norepinephrine excretion levels than those without depressive symptoms (65 µg/day versus 59 µg/day, with adjustment for age, sex, body mass index, smoking, urinary creatinine levels, comorbid illnesses, medication use, and cardiac function). In logistic regression analyses, participants with depressive symptoms were more likely than those without depressive symptoms to have norepinephrine excretion levels in the highest quartile and above the normal range. Depressive symptoms were not associated with dopamine or epinephrine excretion levels. CONCLUSIONS: In patients with coronary disease, depressive symptoms are associated with elevated norepinephrine excretion levels. Future longitudinal studies are needed to determine whether elevations in norepinephrine contribute to adverse cardiac outcomes in patients with depressive symptoms.

This article has been cited by other articles:

				E. L. Fosbol, G. H. Gislason, H. E. Poulsen, M. L. Hansen, F. Folke, T. K. Schramm, J. B. Olesen, D.-M. Bretler, S. Z. Abildstrom, R. Sorensen, et al. Prognosis in Heart Failure and the Value of {beta}-Blockers Are Altered by the Use of Antidepressants and Depend on the Type of Antidepressants Used Circ Heart Fail, November 1, 2009; 2(6): 582 - 590. [Abstract] [Full Text] [PDF]

				L. POZUELO, G. TESAR, J. ZHANG, M. PENN, K. FRANCO, and W. JIANG Depression and heart disease: What do we know, and where are we headed? Cleveland Clinic Journal of Medicine, January 1, 2009; 76(1): 59 - 70. [Abstract] [Full Text] [PDF]

				M. A. Whooley, P. de Jonge, E. Vittinghoff, C. Otte, R. Moos, R. M. Carney, S. Ali, S. Dowray, B. Na, M. D. Feldman, et al. Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease JAMA, November 26, 2008; 300(20): 2379 - 2388. [Abstract] [Full Text] [PDF]

				S. K. Frazier, D. K. Moser, R. Schlanger, J. Widener, L. Pender, and K. S. Stone Autonomic Tone in Medical Intensive Care Patients Receiving Mechanical Ventilation and During a CPAP Weaning Trial Biol Res Nurs, April 1, 2008; 9(4): 301 - 310. [Abstract] [PDF]

				C. Otte, J. McCaffery, S. Ali, and M. A. Whooley Association of a Serotonin Transporter Polymorphism (5-HTTLPR) With Depression, Perceived Stress, and Norepinephrine in Patients With Coronary Disease: The Heart and Soul Study Am J Psychiatry, September 1, 2007; 164(9): 1379 - 1384. [Abstract] [Full Text] [PDF]

				M. S. Roy, A. Roy, and M. Affouf Depression is a Risk Factor for Poor Glycemic Control and Retinopathy in African-Americans With Type 1 Diabetes Psychosom Med, July 1, 2007; 69(6): 537 - 542. [Abstract] [Full Text] [PDF]

				M. A. Whooley Depression and cardiovascular disease: healing the broken-hearted. JAMA, June 28, 2006; 295(24): 2874 - 2881. [Abstract] [Full Text] [PDF]

				A. Gehi, D. Haas, S. Pipkin, and M. A. Whooley Depression and Medication Adherence in Outpatients With Coronary Heart Disease: Findings From the Heart and Soul Study Arch Intern Med, November 28, 2005; 165(21): 2508 - 2513. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us